Unfolding the mystery of premenstrual syndrome (PMS): an overview

Int J Adolesc Med Health. 2022 Sep 19;35(1):9-13. doi: 10.1515/ijamh-2022-0023. eCollection 2023 Feb 1.

Abstract

Physical, emotional, and psychological symptoms are common among women in their reproductive years, particularly during their menstrual cycle's luteal phase and the week before their period. Approximately 5-8 percent of women suffer with premenstrual syndrome, with the majority of those suffering from premenstrual dysphoric disorder (PMDD). Because of the complexity and multifaceted nature of the aetiology, it is yet unknown. Premenstrual syndrome (PMS) is diagnosed entirely on the basis of signs and symptoms, with no particular diagnostic tests available to confirm the diagnosis. Only a small number of therapeutic modalities are backed by clinical data, yet there are many accessible. After providing a brief overview of the disease, the author goes on to discuss the various hypotheses as to why PMS occurs. With an emphasis on tailored treatment based on symptom profile, it examines the wide range of non-pharmacological and pharmaceutical methods that are accessible today.

Keywords: cyclical disorder; premenstrual syndrome; women.

Publication types

  • Review

MeSH terms

  • Emotions
  • Female
  • Humans
  • Premenstrual Dysphoric Disorder* / complications
  • Premenstrual Dysphoric Disorder* / diagnosis
  • Premenstrual Dysphoric Disorder* / therapy
  • Premenstrual Syndrome* / drug therapy
  • Premenstrual Syndrome* / therapy